08.27.20
On July 24, President Trump signed four executive orders (EOs) designed to lower drug prices, adding new fuel to the already raging debate around prescription drug costs.
05.12.20
Privacy is among the many areas of our lives that COVID-19 is radically changing.
03.26.20
The COVID-19 pandemic has adversely impacted vulnerable populations, particularly individuals with opioid use disorder (OUD). Individuals with OUD are more likely to experience homelessness or incarceration and may be at increased risk of exposure to COVID-19.
